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The current investigation was carried out to explore the pharmacological basis of the crude extract of Conyza bonariensis (Cb.Cr) for its use in
constipation and diarrhea.
MATERIALS AND METHODS: The plant extract of Conyza bonariensis (C. bonariensis) was
prepared, isolated guinea-pig ileum and rabbit
jejunum preparations were used to evaluate its
gut modulator effects.
RESULTS: The Cb.Cr (0.3-10 mg/mL) exhibited
spasmogenic effect in isolated guinea-pig ileum
preparation, which was about 19-84% of the acetylcholine maximum. Pretreatment of the tissues with
atropine (0.1 µM) abolished the contractile effect,
similar to acetylcholine. Among the fractions, only
the butanol fraction exhibited atropine sensitive
contractile effect. In isolated rabbit jejunum preparations, Cb.Cr produced appreciable atropine-sensitive spasmogenic effect at lower concentrations
(0.03-0.3 mg/mL) followed by spasmolytic effect at
next higher concentration (1.0 and 3.0 mg/mL).
Cb.Cr caused an inhibition of the high K+ induced contraction in isolated rabbit jejunum
preparation with EC50 value of 0.62 mg/mL. Similarly, verapamil, a standard calcium blocker, inhibited high K+ induced contraction in isolated rabbit
jejunum preparations. Cb.Cr caused a right ward
shift in the Ca++ concentration response curve,
similar to verapamil. Among various fractions of
C. bonariensis, only hexane and ethylacetate fractions showed spasmolytic effects.
CONCLUSIONS: The crude extract of C.
bonariensis contains spasmogenic and spasmolytic constituents, which explains its medicinal use in constipation and diarrhea.

Abstract. – BACKGROUND AND OBJECTIVES:
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Introduction
Conyza bonariensis is a perennial native plant of
the family Asteraceae. It plays an important role in
supplying crude proteins and contributes a significant proportion of herbage fed to ruminant. This
weed is widely available in local range lands of Indo-Pak1 and Middle East2. Moreover, the plant is
also commonly cultivated as an ornamental plant
in gardens. In the South Asian traditional system of
medicine, various parts of the plant are being used
in a variety of ailments. Infusion of the petals is
given as refrigerant and demulcent. Leaves are
used as laxative, root is used in diarrhoea3-4, cough3
while flowers are considered as aphrodisiac, emollient5, and in gastrointestional problems including
diarrhea6. Phytochemical studies of C. bonariensis
revealed the presence of several bioactive constituents including flavonoids, flavonoid glycosides, cyanin glycoside, taraxeryl acetate, β-sitosterol, campesterol, stigmasterol, ergosterol7, cyclopropenoids8 and anthocyanin pigments5.
The plant has also been evaluated pharmacologically for the presence of anticonvulsant4, antitumor9, hypoglycaemic10 and estrogenic11 activities. This study was aimed at exploring the pharmacological rationale of C. bonariensis for its
medicinal use in constipation and diarrhea.

Materials and Methods
Plant Materials
The whole plant of Conyza bonariensis (L.)
Cronq. (Asteraceae) was collected from Oghi,
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Mansehra, Pakistan, in November 2002, and identified by Mr. Jan Alam (Taxanomist) at the Department of Botany, University of Karachi, Pakistan. A voucher specimen (KUH G. H. No.
68220) has been deposited at the herbarium of the
above Department.
Extraction and Fractionation
The air dried whole plant of Conyza bonariensis (35 kg) was exhaustively extracted with
MeOH (50 L×3) at room temperature. The extract was evaporated to yield the residue (815 g),
which was partitioned between n-hexane (110 g),
CHCl3 (90 g), EtOAc (95 g), n-BuOH (495 g)
and water (25 g).
Drugs and Animals
Acetylcholine perchlorate, atropine sulphate,
potassium chloride, histamine diphosphate salt
and verapamil hydrochloride, were purchased
from Sigma Chemicals Co, St Louis, MO, USA
and pyrilamine maleate USP grade was purchased from RB Industries Inc., Chicago, IL,
USA. All other chemicals used were of the highest analytical grade available. All drugs were dissolved in distilled water and dilutions were made
fresh in normal saline (0.9% sodium chloride) on
the day of experiment.
Animals used in this study were housed at the
Animal House of The Aga Khan University, maintained at 23-25°C and were given a standard diet
and tap water. Experiments performed complied
with the rulings of the Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council (NRC, 1996). Rabbits (1.01.5 kg) and guinea pigs (500-600 g) of local breed
and either sex were used for this study. Animals
had free access to water but food was withdrawn 24
hours prior to the experiment. Rabbits were sacrificed by a blow on the back of the head and guinea
pigs were sacrificed by cervical dislocation.
Isolated Tissue Preparations
The spasmogenic and spasmolytic activities of
the plant material were studied using isolated
guinea-pig ileum and rabbit jejunum preparations, as described previously12. Respective segments of 2 cm length were suspended in a 10 mL
tissue baths containing Tyrode’s solution, aerated
with a mixture of 95% oxygen and 5% carbon
dioxide and maintained at 37oC. The composition
of the Tyrode’s solution was: KCl 2.68, NaCl
136.9, MgCl 2 1.05, NaHCO 3 11.90, NaH 2PO 4
0.42, CaCl2 1.8 and glucose 5.55 mM. Intestinal

responses were recorded isotonically using BioScience transducers and oscillographs. Each tissue was allowed to equilibrate for at least 30 min
before the addition of any drug.
Under these experimental conditions, guinea
pig ileum behaved as a quiescent preparation and
is considered more useful for spasmogenic activity13, whereas rabbit jejunum exhibits spontaneous rhythmic contractions, allowing to test the
relaxant (spasmolytic) activity directly without
the use of an agonist14. The contractile effect of
the test material was assessed as the percent of
the maximum effect produced by the control
drug, acetylcholine (1.0 µM).
Determination of calcium antagonist activity:
To assess whether the spasmolytic activity of the
test substances, was through calcium channel
blockade (CCB), K+, as KCl, was used to depolarize the preparations according to method15. High
K+ (80 mM) was added to the tissue bath, which
produced a sustained contraction. Test materials
were then added in a cumulative fashion to obtain
concentration-dependent inhibitory responses16.
The relaxation of intestinal preparations, precontracted with K+ (80 mM) was expressed as percent
of the control response mediated by K+.
To confirm the calcium antagonist activity of
test substances, the tissue was allowed to stabilize
in normal Tyrode’s solution, which was then replaced with Ca++-free Tyrode’s solution containing
EDTA (0.1 mM) for 30 min in order to remove
Ca++ from the tissues. This solution was further replaced with a K+-rich and Ca++-free Tyrode’s solution, having the following composition: KCl 50,
NaCl 91.04, MgCl 2 1.05, NaHCO 3 11.90,
NaH2PO4 0.42, glucose 5.55 and EDTA 0.1 mM.
Following an incubation period of 30 min, control
concentration-response curves (CRCs) of Ca++
were obtained. When the control CRCs of Ca++
were found super-imposable (usually after two cycles), the tissue was pretreated with the plant extract for 60 min to test a possible CCB effect. The
CRCs of Ca++ were developed in the presence of
different concentrations of the test material.
Statistical Analysis
The data is expressed in mean ± standard error
of the mean (SEM). The median effective concentrations (EC50 values) were obtained using
Graph Pad Prism version 4. Data was analyzed
by one way ANOVA followed by the StudentNewman-Keuls multiple comparison test when
significant difference were present. p < 0.05 was
considered statistically significant.
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Results
The plant extracts of C. bonariensis and its
various fractions were evaluated for its effect in
isolated rabbit jejunum and guinea pig ileum
preparations. In isolated guinea-pig ileum preparation, Cb.Cr caused concentration-dependent
contractile effect, which was about 19-84% of
acetylcholine maximum effect (Figure 1A and
B). Pretreatment of the tissues with atropine (0.1
µM), abolished the contractile effect of the crude
extract, similar to that of acetylcholine. Among
the fractions studied, only the butanol fraction of
C. bonariensis (Cb.BUOH) exhibited atropine

sensitive contractile effect (Figure 1C) in isolated
guinea-pig ileum preparations, while other fractions, such as, ethylacetate (EtAc) and hexane
(Hex) were found without any contractile effect
at the maximum concentrations used.
The Cb.Cr and its fractions were further studied in isolated rabbit jejunum preparations. When
tested on spontaneous contractions, Cb.Cr (0.33.0 mg/mL) caused relaxation of the spontaneous
contraction of isolated rabbit jejunum preparation with an appreciable spasmogenic effect at
lower concentrations of 0.03-0.3 mg/mL (Figure
2). Pre-treatment of tissue with atropine (0.1 µM)
completely abolished the spasmogenic effect of

B
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Figure 1. Tracings showing the dose dependent contractile effect of the crude extract of Conyza bonariensis (Cb.Cr) in the absence and presence of atropine in the isolated guinea-pig ileum preparations (A). Acteycholine (ACh) was used as positive control
and concentration-response curve for the spasmogenic effects of Cb.Cr (B) and butanol fraction; BUOH (C) without and with atropine in isolated guinea-pig ileum preparations. Data are mean ± SEM of percentage of ACh maximum contractions (n=6).
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Figure 2. Tracing showing the spasmolytic effect of crude extract of Conyza bonariensis on spontaneously contracting isolated rabbit jejunum preparations in the absence and presence of atropine.

the plant extract (Figure 2) and relaxation was
obtained at significantly (p < 0.001) lower concentration with respective EC50 values, in the absence and presence of atropine, were 0.44 and
0.05 mg/mL (Figure 3 A).
Cb.Cr caused a concentration-dependent relaxation of K+-induced contractions with EC50 of
0.62 mg/mL (Figure 3A). Similar to the effects
of Cb.Cr, Verapamil, used as a reference standard produced marked inhibition of spontaneous
and high K+-induced contractions in isolated rabbit jejunum preparation (Figure 3B).
Activity-directed fractionation revealed that
the ethylacetate fraction of C. bonariensis
(Cb.EtAc) antagonized spontaneous and high K+induced contractions in rabbit jejunum preparations with EC 50 of 0.85 mg/mL (Figure 3 C).
Similarly hexane fraction of C. bonariensis
(Cb.Hex) caused relaxation of the spontaneous
and high K+-induced contractions in isolated rabbit jejunum preparations at comparatively lower
concentrations than the parent crude extract with
EC50 value of 0.25 mg/mL (Figure 3D). Cb.Cr
caused a rightward shift in the Ca++ concentra-

tion-response curves, constructed in the Ca++-free
and K+ rich medium (Figure 4A), similar to verapamil (Figure 4B).

Discussion
This study was aimed at exploring the pharmacological basis for the use of Conyza bonariensis
in the management of constipation and diarrhea.
Isolated guinea-pig preparation was used to test
the possible contractile effect of the crude extract
of C. bonariensis, which is considered more suitable preparation for the demonstration of spasmogenic effect12. Cb.Cr caused concentration-dependent contractile effect in isolated guinea-pig
ileum preparation. Pretreatment of tissues with
atropine (0.1 µM), abolished the contractile effect of the plant extract, similar to that of acetylcholine, indicating the involvement of cholinergic receptors in the observed contractile effect of
the plant extracts. Acetylcholine is a neurotransmitter released by the parasympathetic nervous
system, mediates its action in the gut by stimula555
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Figure 3. Inhibitory effect of the crude extract of Conyza bonariensis; Cb.Cr (A), verapamil (B), ethylacetate; Cb.EtAc (C)
and hexane; Cb.Hex fraction (D) on spontaneous and high K+-induced contractions in isolated rabbit jejunum preparations.
Values are mean ± SEM (n=4-6). ***p < 0.001 compared to spontaneous contractions without atropine.

B

Figure 4. Effect of different concentration of (A) the crude extract of Conyza bonariensis (Cb.Cr) ad (B) verapamil on Ca++
concentration-response curves in isolated rabbit jejunum preparations. Values are mean ± SEM (n= 4-6). **p < 0.01, ***p <
0.001 compared to respective controls.
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tion of muscarinic M3 receptor subtypes and atropine blocks all muscarinic receptor sites.
Acetylcholine plays an important physiological
role to regulate the peristaltic movements of the
gut17. Cholinergic agents are known to increase
the secretory and motor activity of the gut18. The
observed contractile effect of the crude extract,
similar to that of acetylcholine, may explain the
medicinal use of C. bonariensis in constipation18.
However, the co-existence of other mechanisms
cannot be excluded completely.
Activity guided fractionation study revealed
that contractile constituents of C. bonariensis
were concentrated in butanol fraction which can
be used effectively in the treatment of constipation. The crude extract and its fractions were further studied in isolated rabbit jejunum preparations. C. bonariensis plant extract produced relaxation of the spontaneous contraction of isolated
rabbit jejunum preparation with an appreciable
spasmogenic effect at lower concentrations, suggesting that the plant extract has got spasmogenic
effect which is accompanied by a spasmolytic effect. Similar to the effect of C. bonariensis in the
guinea pig ileum preparation, the spasmogenic effect of the crude extract was abolished with pretreatment of the tissue with atropine (0.1 µM), an
antimuscarinic agent19. In atropine pre-treated tissues the relaxation was obtained at lower concentration. The relaxant effect of C. bonariensis in
the absence and presence of atropine were significantly different from each other, indicating the
presence of spasmogenic and spasmolytic constituents in the plant extracts.
We have previously observed that the spasmolytic constituents present in medicinal plants
usually mediate their effect through calcium
channel blockade (CCB) properties20-21. To see
whether the spasmolytic effect of C. bonariensis
observed in this study is mediated through CCB,
a high concentration of K+ (80 mM) was used
which caused sustained contraction. The crude
extract caused a concentration-dependent relaxation of K+-induced contractions, similar to verapamil. K+ at high concentrations (>30 mM) is
known to cause smooth muscle contractions
through opening of voltage-dependent slow Ca++
channels, thus allowing influx of extracellular
Ca++ causing a contractile effect22. Thus the inhibitory effect of the plant extract against K+-induced contractions can be visualized as the CCB.
The presence of calcium antagonist(s) in the
plant extract was confirmed when it caused a
rightward shift in the Ca ++ concentration-re-

sponse curves, constructed in the Ca++-free and
K+ rich medium, similar to that caused by verapamil, a standard Ca channel blocker22. Interestingly CCBs are known to be useful as antispasmodic and antidiarrhoeal 23. Activity-directed
fractionation studies revealed that the relaxant
constituents of C. bonariensis plant extract were
concentrated in the hexane and ethylacetate fraction. Both these fraction caused a significant relaxant effect in spontaneous and high K+-induced
contractions in isolated rabbit jejunum preparations. In contrast to their parent crude extract, the
hexane and ethylacetate fractions of C. bonariensis did not produce any contractile effect in the
isolated rabbit jejunum preparations.

Conclusions
The data from the present study indicate that
the crude extract of C. bonariensis contains spasmogenic constituents, which are separated into
the butanol fraction and spasmolytic constituents,
concentrated in the ethylacetate and hexane fractions. The spasmogenic activity of the plant extract was similar to acetylcholine while the spasmolytic effect resembled calcium channel blockers. Moreover, theses finding validate the medicinal use of the C. bonariensis in constipation and
diarrhea.
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